---

$1.66

+0.0650 ( +4.09% ) 763.8K

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2023-10-05	Sale	-5267.00	Brenner Martin
2023-10-03	Sale	-4215.00	Brenner Martin
2023-08-30	Sale	-5011.00	Brenner Martin
2023-08-24	Sale	-60000.00	Duran Felipe
2023-08-24	Sale	-120000.00	Brenner Martin